Jack Persico - Profile and Journalist Details
Find journalists that align with your industry, location and vision. Unlock Jack Persico's full journalist profile, including location, coverage topics, current employer, biography and preferences. Sign up today and start building journalist relationships that fuel your startup's growth.
Get connected with journalists today
Jack Persico
Verified
Editorial Director, Review Group, Jobson Medical Information
Philadelphia
Beats
Not applicable
Content
By Jack Persico Verified| Review of Optometry Verified When you first identify a medical condition in a patient, you’re usually met with two strong emotions simultaneously: pride in your clinical acumen and, perhaps, anxiety over how to proceed. Suddenly, you’re on the hook to make a whole lot of judgment calls on the patient’s behalf. Should they begin therapy? If so, with what? How soon and how often should they be seen for follow-up? What criteria should you use to gauge success or failure of the treatment?
By Jack Persico Verified| Review of Optometry Verified When you first identify a medical condition in a patient, you’re usually met with two strong emotions simultaneously: pride in your clinical acumen and, perhaps, anxiety over how to proceed. Suddenly, you’re on the hook to make a whole lot of judgment calls on the patient’s behalf. Should they begin therapy? If so, with what? How soon and how often should they be seen for follow-up? What criteria should you use to gauge success or failure of the treatment?
By Jack Persico Verified| Review of Optometry Verified Another day, another Ozempic article. Ever since last summer, when JAMA Ophthalmology published worrisome findings showing an increased risk of NAION in patients using semaglutide, the active ingredient in Ozempic and Wegovy, additional studies have been coming fast and furious—and they often contradict each other. Here’s a timeline to catch you up. In July 2024, Harvard researchers published an observational study involving 555 patients taking semaglutide for either weight loss or diabetes.
Company Info
Jobson Medical Information
Jobson Optical Group is a prominent healthcare information, education, and marketing services company focused on the eyecare industry. It offers a diverse range of services aimed at empowering eyecare professionals and enhancing patient care. These services include marketing and advertising solutions, educational resources, and business intelligence reports that help optical businesses make informed decisions. The company publishes influential magazines and online platforms, such as Vision Monday and 20/20 Magazine, along with research reports like the ECP Income Study. Jobson Optical Group's offerings are tailored for eyecare professionals, including optometrists, ophthalmologists, and opticians, ensuring they stay updated on industry trends and best practices.
New York, New York, United States
+1 212-274-7175
Founded: 1958